title: Vitamin B6 supplementation increases immune responses in critically ill patients.
abstract: OBJECTIVE
  To investigate whether vitamin B6 supplementation has a beneficial effect on immune responses in critically ill patients.
  
  
  METHODS
  A single-blind intervention study.
  
  
  METHODS
  The study was performed at the Taichung Veterans General Hospital, the central part of Taiwan.
  
  
  METHODS
  Fifty-one subjects who stayed over 14 days in the intensive care unit completed the study. Subjects were not treated with any vitamin supplement before the intervention.
  
  
  METHODS
  Patients were randomly assigned to one of three groups, control (n = 20), a daily injection of 50 mg vitamin B-6 (B6 -50, n=15), or 100 mg vitamin B-6 (B6 -100, n = 16) for 14 days.
  
  
  METHODS
  Plasma pyridoxal 5'-phosphate (PLP), pyridoxal (PL), 4-pyridoxic acid (4-PA), erythrocyte alanine (EALT-AC) and aspartate (EAST-AC) aminotransaminase activity coefficient, and urinary 4-PA were measured. The levels of serum albumin, hemoglobin, hematocrit, high-sensitivity C-reactive protein (hs-CRP) and immune responses (white blood cell, neutrophils, total lymphocytes count (TLC), T- (CD3) and B-(CD19) lymphocytes, T-helper (CD4) and suppressor (CD8) cells) were determined.
  
  
  RESULTS
  Plasma PLP, PL, 4-PA and urinary 4-PA concentrations significantly increased in two treated groups. T-lymphocyte and T-helper cell numbers and the percentage of T-suppressor cell significantly increased on day 14 in the B6 -50 group. Total lymphocyte count, T-helper and T-suppressor cell numbers, the percentage of T-lymphocyte cells and T-suppressors significantly increased in the B6 -100 group at the 14th day. There were no significant changes with respect to immune responses in the control group over 14 days.
  
  
  CONCLUSIONS
  A large dose of vitamin B6 supplementation (50 or 100 mg/day) could compensate for the lack of responsiveness of plasma PLP to vitamin B6 intake, and further increase immune response of critically ill patients.
  
  
  BACKGROUND
  This study was supported by the National Science Council, Taiwan, Republic of China (NSC-92-2320-B-040-026).
authors: Critical Care and Respiratory Therapy, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China. ych@csmu.edu.tw
authors: C-H
authors: CH
authors: Cheng
authors: S-J
authors: SJ
authors: Chang
authors: B-J
authors: BJ
authors: Lee
authors: K-L
authors: KL
authors: Lin
authors: Y-C
authors: YC
authors: Huang